School of Medicine
Showing 1-20 of 109 Results
-
Solmaz Nabipour
Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine
Bio Dr. Nabipour earned her medical degree and completed anesthesiology residency at USC Keck School of Medicine and served as a Chief Resident and was selected as the Resident of the Year. Upon completing residency, she practiced for ten years as a partner in a private anesthesia group in Santa Cruz, California. During this time, she served as a member of the Credentials Committee and Medical Executive Committee. She also held multiple leadership positions including Chair of the Department of Surgery, as well as the Medical Director of Anesthesia Services, working closely with her surgical colleagues to improve efficiency and patient experience in the operating room. Dr. Nabipour joined the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine as a Clinical Assistant Professor in 2018 and is the Anesthesiology Medical Director at the Stanford Cancer Center South Bay. She is the co-founder and co-director of the Stanford Anesthesiology Mentorship Program and Anesthesiology Scholars Program Inter-Exchange (ASPIRE) and is an advocate for faculty development and diversity, equity and inclusion both locally and nationally while also currently enrolled in law school at Santa Clara University.
-
Kari Nadeau, MD, PhD
Naddisy Foundation Professor of Pediatric Food Allergy, Immunology and Asthma, Professor of Pediatrics, Senior Fellow at the Woods Institute and Professor, by courtesy, of Otolaryngology and of Epidemiology and Population Health at LPCH
Current Research and Scholarly Interests Dr. Kari Nadeau?s laboratory and clinical research is focused on understanding the role of genes and the environment, including climate change, on the rising incidence of allergies and asthma. By understanding the genetic, epigenetic, cellular, and humoral factors that mediate immune tolerance or allergy to foods, aeroallegens, and air pollutants (e.g., diesel emissions and wildfires), her research is laying the groundwork for potential future therapies to prevent and cure allergies and asthma.
-
Helen Nadel
Clinical Professor, Radiology - Pediatric Radiology
Current Research and Scholarly Interests Clinical research and scholarly interests include topics in Pediatric Nuclear Medicine to include AI evaluation for scintigraphic quantitation, PET MR evaluation of optimized techniques for use in pediatric patient managment
-
Claude M. Nagamine, DVM, PhD
Associate Professor of Comparative Medicine at the Stanford University Medical Center
Current Research and Scholarly Interests Mouse models to study murine and human infectious diseases. These colloborative studies include dengue virus, zika virus, adeno-associated virus, coxsackie virus, enterovirus 71, enterohepatic helicobacters, campylobacters, and anaplasma.
-
Seema Nagpal, MD
Clinical Associate Professor, Neurology & Neurological Sciences
Current Research and Scholarly Interests I'm a board certified neuro-oncologist who treats both primary brain tumors as well as metastatic disease to the brain and nervous system. My research concentrates on clinical trials for patients with late-stage central nervous system cancer. I have a special interest in leptomeningeal disease, a devastating complication of lung and breast cancers. I collaborate with Stanford scientists to detect this disease earlier, and with our breast and lung oncologists to improve outcomes for patients.
-
Hiromitsu (Hiro) Nakauchi
Professor of Genetics (Stem Cell)
Current Research and Scholarly Interests Translation of discoveries in basic research into practical medical applications
-
Yusuke Nakauchi
Instructor, Stanford Cancer Institute
Current Research and Scholarly Interests From 2005 to 2010, my work as a clinical hematology fellow allowed me to experience first-hand how scientific advances that started in a laboratory can transform the lives of patients. While many of my patients were cured of their disease with allogeneic hematopoietic stem cell transplantation, underscoring the importance of anti-tumor immunotherapy in eradicating leukemia, I witnessed face-to-face their suffering from the long-term consequence of graft-versus-host disease (GVHD). This experience was ultimately what drove me to engage in research to discover novel therapies. For this reason, I embarked on a PhD program in 2010 to design antibody therapy to (i) target GVHD and (ii) target hematological malignancies. Under the mentorship of Professor Hiromitsu Nakauchi at the University of Tokyo, an international leader in hematopoiesis, I developed allele-specific anti-human leukocyte antigen (HLA) monoclonal antibodies for severe GVHD caused by HLA-mismatched hematopoietic stem cell transplantation (Nakauchi et al., Exp Hematol, 2015). This study was the first to find that anti-HLA antibodies can be used therapeutically against GVHD. That success gave me the motivation and confidence to further my research beyond targeting GVHD, to targeting leukemic stem cells through my current postdoctoral fellowship in the laboratory of Professor Ravindra Majeti, Department of Hematology at Stanford University.
Many people suffer from leukemia each year, but we still don?t know how to completely cure it. Recent advances in sequencing technologies have tremendously improved our understanding of the underlying mutations that drive hematologic malignancies, although, the reality is that the majority of the mutations are not easily ?druggable? and the discovery of these mutations has not yet made a significant impact in patient outcomes. I view this perhaps the most crucial challenges facing a translational cancer researcher like myself. My current research is a major step toward my long term goal to make personalized medicine a reality for patients with acute myeloid leukemia (AML) and other hematologic malignancies. Although my research is focused on targeting Ten-Eleven Translocation methylcytosine dioxygenase-2 (TET2) mutations, I anticipate it will lead to a better understanding of the cell context requirement for TET2 mutations in AML and help identify the critical cells to target to both prevent the development of de novo leukemia and halt relapse. It may also prove of value to understanding of the biology of a range of other cancers. -
Shweta S. Namjoshi MD MPH CNSC
Clinical Assistant Professor, Pediatrics - Gastroenterology
Bio Dr. Namjoshi specializes in the care and support of children with intestinal failure on home parenteral nutrition (PN). Her research interests include long term outcomes for patients on home PN, iron in gastrointestinal diseases, renal and bone health in intestinal failure, clinical pathologic correlates in intestinal failure, and the assessment of congenital enteropathies.
-
Sandy Napel
Professor of Radiology (Integrative Biomedical Imaging Informatics) and, by courtesy, of Medicine (Medical Informatics) and of Electrical Engineering
Current Research and Scholarly Interests My research seeks to advance the clinical and basic sciences in radiology, while improving our understanding of biology and the manifestations of disease, by pioneering methods in the information sciences that integrate imaging, clinical and molecular data. A current focus is on content-based radiological image retrieval and integration of imaging features with clinical and molecular data for diagnostic, prognostic, and therapy planning decision support.
-
Diana Naranjo
Clinical Professor, Pediatrics - Endocrinology and Diabetes
Bio As a licensed clinical psychologist working in diabetes and Cystic Fibrosis clinics for the past 10 years, Dr. Naranjo focuses on the psychosocial needs of patients and families with diabetes and CF. Through clinical research, she aims to understand barriers and facilitators to diabetes self-management, how families and individuals with diabetes respond to health technology, and how to best provide services that engage youth and their families. She is a member of the Stanford Diabetes Research Center.
-
Sanjiv Narayan
Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Narayan directs the Computational Arrhythmia Research Laboratory, whose goal is to define the mechanisms underlying complex human heart rhythm disorders, to develop bioengineering-focused solutions to improve therapy that will be tested in clinical trials. The laboratory has been funded continuously since 2001 by the National Institutes of Health, AHA and ACC, and interlinks a disease-focused group of clinicians, computational physicists, bioengineers and trialists.
